Ming-Kuei Jang
Chief Executive Officer at Aprinoia Therapeutics, Inc.
Ming-Kuei Jang active positions
| Companies | Position | Start | End |
|---|---|---|---|
Aprinoia Therapeutics, Inc.
 Aprinoia Therapeutics, Inc. BiotechnologyHealth Technology Aprinoia Therapeutics, Inc. operates as a drug discovery and early development company. The company was founded by Ming-Kuei Jang in May 20, 2015 and is headquartered in Taipei, Taiwan. | Chief Executive Officer | 2015-05-19 | - |
| Founder | 2015-05-19 | - | |
Aprinoia Therapeutics, Inc. /US/
 Aprinoia Therapeutics, Inc. /US/ BiotechnologyHealth Technology Aprinoia Therapeutics, Inc. operates as a global clinical-stage biopharmaceutical company. It develops imaging diagnostic tools, targeted therapy drugs, and other products. The company was founded in 2015 and is headquartered in Cambridge, MA. | Founder | 2014-12-31 | - |
| Chairman | 2014-12-31 | - | |
| Chief Executive Officer | 2015-01-31 | 2023-06-30 | |
| APRINOIA Therapeutics LLC | Chief Tech/Sci/R&D Officer | - | - |
Career history of Ming-Kuei Jang
Former positions of Ming-Kuei Jang
| Companies | Position | Start | End |
|---|---|---|---|
| Glaxosmithkline China Ltd. | Corporate Officer/Principal | 2010-02-28 | 2012-02-29 |
Training of Ming-Kuei Jang
| Boston University School of Medicine | Doctorate Degree |
| National Taiwan University | Undergraduate Degree |
Statistics
International
| United States | 4 |
| Taiwan | 3 |
| China | 2 |
Operational
| Chief Executive Officer | 2 |
| Founder | 2 |
| Chairman | 1 |
Sectoral
| Health Technology | 3 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 4 |
|---|---|
Aprinoia Therapeutics, Inc.
Aprinoia Therapeutics, Inc. BiotechnologyHealth Technology Aprinoia Therapeutics, Inc. operates as a drug discovery and early development company. The company was founded by Ming-Kuei Jang in May 20, 2015 and is headquartered in Taipei, Taiwan. | Health Technology |
Aprinoia Therapeutics, Inc. /US/
Aprinoia Therapeutics, Inc. /US/ BiotechnologyHealth Technology Aprinoia Therapeutics, Inc. operates as a global clinical-stage biopharmaceutical company. It develops imaging diagnostic tools, targeted therapy drugs, and other products. The company was founded in 2015 and is headquartered in Cambridge, MA. | Health Technology |
| APRINOIA Therapeutics LLC | |
| Glaxosmithkline China Ltd. |
- Stock Market
- Insiders
- Ming-Kuei Jang
- Experience
